focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
6.4 to sell, out of auction.
Looks like in auction at 6.2
Straight to auction I think
6p already…WOW
Rerate coming hopefully, we’ve waited a long time for this.
HEMO and REDX are both great investments.
Currently we have a 45m mkt cap, what are we worth now?
Maybe we will get that £1 party we’ve all been talking about for years 🤞
I’d be happy with 50p 😃
We need a HE1 style rise here, some of us LTH are in here with an average above 10p. I have seen shares go from 4p to over £10 so here’s to a good day for all holders.
We were nearly double the current price only one month ago.
Non dilutive funding, what’s not to like about this company or have I totally missed something.
Video also available on YouTube, interesting interview.
Jazz Pharmaceuticals plc and Redx Pharma plc have signed a definitive agreement under which Jazz will acquire Redx's KRAS (Kirsten rat sarcoma virus) inhibitor program. Jazz and Redx will collaborate to advance candidates through IND-enabling studies; Jazz will be responsible for all clinical development, regulatory, manufacturing and commercialisation activities.
"KRAS is a well-validated oncology target and there remains a high unmet need for innovation in this area based on challenges in developing molecules to target specific KRAS mutations. Redx has discovered a number of preclinical KRAS candidates and we plan to leverage our collective oncology development expertise to identify and advance the most promising molecules toward the clinic," said Robert Lannone, M.D., M.S.C.E., executive vice president, global head of research and development of Jazz Pharmaceuticals. "This transaction further expands our early-stage oncology pipeline, and we are excited to explore novel approaches to improving treatment options for cancer patients."
Lisa Anson, Chief Executive Officer of Redx, commented: "Once again, our distinguished expertise in medicinal chemistry has been recognised and we are pleased to secure another strategic transaction with Jazz, with whom we have a track record of collaboration. This agreement will allow us to collaborate on the advancement of novel KRAS inhibitors and we look forward to supporting Jazz in progressing these candidates through IND-enabling studies. Partnerships remain a key pillar of our corporate strategy, allowing us to advance what we believe are differentiated molecules in areas of high unmet need, while also creating long-term shareholder value through non-dilutive funding, with the upfront milestone payment from this agreement extending our current cash runway into 2025."
Why all the huge trades from yesterday showing?
There’s been chunky buys going through all day, I’ve added to my holding and feel confident this will do well.
I’ve added a few more, let’s see what the next few weeks/months bring.
After yesterdays RNS this price is just ridiculous
Around 6-7 large trades totalling nearly £100k have gone through and still we are down 10%
You’re right, it is pure manipulation, look at all the large buys that have gone though today.